Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease, with the World Health Organization designating it as a global priority. There are several risk factors for its occurrence, which are divided into two major categories: modifiable (diabetes, hypertension, body weight, sleep, smoking) and non-modifiable (age, gender, genetic factors). Many drugs of various categories have been used and tested, with no successful results in terms of prevention and treatment. The combination of medication with the management of modifiable risk factors can significantly help prevent and weaken the course of the disease. Due to the increase in the average life expectancy, in the coming years there will be a significant increase in the number of cases with AD, highlighting the need to create support and care networks for these patients.